Thursday, April 25, 2024 7:41:11 AM
Keeping Shs DOWN
Based on my extensive experience
which no one has
1) as an equity analyst @#1 Merrill Lynch & recommending a $5 Buy of NYSE co went to $25 in 18 mos, SEC Subpoena Alleging In Possession of Insider Info
2) Meeting the CEO of Pershing now a key oper of BankNY Mellon
in Stock Loans
3)Worked with Elite Hedge Funds
4)Portfolio Manager
Keeping the Shares DOWN is Standard Operating Procedures PERIOD.
I have known for over a decade:
Hi Freq Trading
ALGO's
Paying for Order Flow
NAKED SHORTING
Stock Loans Depts big countercyclical profit center
MARKET is RIGGED against retail!
Induces Fear of the unknown
Mind games for Nervous Nelly inducing recent sales IE GermanCol SALES!
HOWEVER
CEO Linda Powers IMHO will smoke them ALL OUT!
Misguided ones:
NO Buyout: No BP can afford PERIOD
The Danish Dude, myself & others have AGREED:
Merging RevImmune will require a
NEW CUSIP
Besides there are no Call Options for covering.
This EPIC was expected since 2014
and played conservatively versus the many thousands SPOOKED
Just look at my FIRST post in 2014.
BTW retired at 41 yo.
DIFFERENT STROKES for DIFFERENT FOLKS
Based on my extensive experience
which no one has
1) as an equity analyst @#1 Merrill Lynch & recommending a $5 Buy of NYSE co went to $25 in 18 mos, SEC Subpoena Alleging In Possession of Insider Info
2) Meeting the CEO of Pershing now a key oper of BankNY Mellon
in Stock Loans
3)Worked with Elite Hedge Funds
4)Portfolio Manager
Keeping the Shares DOWN is Standard Operating Procedures PERIOD.
I have known for over a decade:
Hi Freq Trading
ALGO's
Paying for Order Flow
NAKED SHORTING
Stock Loans Depts big countercyclical profit center
MARKET is RIGGED against retail!
Induces Fear of the unknown
Mind games for Nervous Nelly inducing recent sales IE GermanCol SALES!
HOWEVER
CEO Linda Powers IMHO will smoke them ALL OUT!
Misguided ones:
NO Buyout: No BP can afford PERIOD
The Danish Dude, myself & others have AGREED:
Merging RevImmune will require a
NEW CUSIP
Besides there are no Call Options for covering.
This EPIC was expected since 2014
and played conservatively versus the many thousands SPOOKED
Just look at my FIRST post in 2014.
BTW retired at 41 yo.
DIFFERENT STROKES for DIFFERENT FOLKS
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
